Incyte (INCY) Inventory (2012 - 2026)
Incyte posted quarterly Inventory of $115.6 million for Q1 2026, up 80.73% year-on-year from $64.0 million in Q1 2025, and up 14.41% on a QoQ basis from $101.1 million in Q4 2025.
Incyte (INCY) has 15 years of Inventory data on file, last reported at $115.6 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 80.73% year-over-year to $115.6 million; the trailing twelve-month figure through Mar 2026 stood at $115.6 million (up 80.73% YoY), and the FY2025 full-year result was $101.1 million, up 71.66% from the prior year.
- Inventory for Q1 2026 stood at $115.6 million, up from $101.1 million in the prior quarter.
- Across five years, Inventory topped out at $115.6 million in Q1 2026 and bottomed at $35.5 million in Q1 2022.
- The 5-year median for Inventory is $63.0 million (2023), against an average of $65.6 million.
- The widest annual swing landed in 2022, when Inventory soared 226.84%; it then slumped 34.13% in 2023.
- A 5-year view of Inventory shows it stood at $42.0 million in 2022, then jumped by 49.95% to $63.0 million in 2023, then slipped by 6.51% to $58.9 million in 2024, then soared by 71.66% to $101.1 million in 2025, then climbed by 14.41% to $115.6 million in 2026.
- The last three Inventory figures came in at $115.6 million (Q1 2026), $101.1 million (Q4 2025), and $83.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 115.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.62 Mn |
| Dec 31, 2025 | 101.06 Mn |
| Sep 30, 2025 | 83.40 Mn |
| Jun 30, 2025 | 83.42 Mn |
| Mar 31, 2025 | 63.98 Mn |
| Dec 31, 2024 | 58.87 Mn |
| Sep 30, 2024 | 70.44 Mn |
| Jun 30, 2024 | 100.70 Mn |
| Mar 31, 2024 | 63.60 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Sep 30, 2023 | 57.20 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 40.88 Mn |
| Dec 31, 2022 | 42.00 Mn |
| Sep 30, 2022 | 45.87 Mn |
| Jun 30, 2022 | 54.50 Mn |
| Mar 31, 2022 | 35.50 Mn |
| Dec 31, 2021 | 27.90 Mn |
| Sep 30, 2021 | 21.30 Mn |
| Jun 30, 2021 | 16.68 Mn |
| Mar 31, 2021 | 16.70 Mn |
| Dec 31, 2020 | 16.43 Mn |
| Sep 30, 2020 | 17.00 Mn |
| Jun 30, 2020 | 16.30 Mn |
| Mar 31, 2020 | 13.98 Mn |
| Dec 31, 2019 | 11.40 Mn |
| Jun 30, 2019 | 6.53 Mn |
| Mar 31, 2019 | 7.13 Mn |
| Dec 31, 2018 | 6.97 Mn |
| Sep 30, 2018 | 5.99 Mn |
| Jun 30, 2018 | 5.87 Mn |
| Mar 31, 2018 | 4.63 Mn |
| Dec 31, 2017 | 6.48 Mn |
| Sep 30, 2017 | 3.26 Mn |
| Jun 30, 2017 | 2.93 Mn |
| Mar 31, 2017 | 3.96 Mn |
| Dec 31, 2016 | 4.11 Mn |
| Sep 30, 2016 | 4.08 Mn |
| Jun 30, 2016 | 6.12 Mn |
| Mar 31, 2016 | 1.31 Mn |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | 2.43 Mn |
| Jun 30, 2015 | 1.90 Mn |
| Mar 31, 2015 | 2.41 Mn |
| Dec 31, 2014 | 358,000.00 |
| Sep 30, 2014 | 402,000.00 |
| Jun 30, 2014 | 269,000.00 |
| Mar 31, 2014 | 347,000.00 |
| Dec 31, 2013 | 406,000.00 |
| Sep 30, 2013 | 359,000.00 |
| Jun 30, 2013 | 133,000.00 |
| Mar 31, 2013 | 189,000.00 |
| Dec 31, 2012 | 278,000.00 |
| Sep 30, 2012 | 190,000.00 |
| Jun 30, 2012 | 188,000.00 |